Ceritinib Nitroso Impurity 2
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Ceritinib is used to treat metastatic (cancer that has already spread) non-small cell lung cancer in patients who have a certain type of abnormal anaplastic lymphoma kinase (ALK) gene. Your doctor will test for the presence of this gene. Ceritinib is an antineoplastic (cancer) agent.Ceritinib Nitroso Impurity 2 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Ceritinib Nitroso Impurity 2 CAS NO:NA chemically represented as N-(5-Chloro-4-((2-(isopropylsulfonyl)phenyl)amino)pyrimidin-2-yl)-N-(2-isopropoxy-5-methyl-4-(piperidin-4-yl)phenyl)nitrous amide. Synchemia is the leading manufacturing and exporter of Ceritinib Nitroso Impurity 2 . We supply Ceritinib Nitroso Impurity 2 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N014839 |
| CAS No | NA |
| Mol.F. | C12H16N4O3S |
| Mol.Wt. | 296.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014840 |
| CAS No | NA |
| Mol.F. | C28H30N6O9 |
| Mol.Wt. | 594.6 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014841 |
| CAS No | NA |
| Mol.F. | C22H20N4O8 |
| Mol.Wt. | 468.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014842 |
| CAS No | NA |
| Mol.F. | C19H17ClN4O6S |
| Mol.Wt. | 464.9 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014843 |
| CAS No | NA |
| Mol.F. | C12H16N4O5 |
| Mol.Wt. | 296.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014844 |
| CAS No | NA |
| Mol.F. | C13H16ClN3O4 |
| Mol.Wt. | 313.7 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014845 |
| CAS No | NA |
| Mol.F. | C20H22ClN5O6S |
| Mol.Wt. | 495.9 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014846 |
| CAS No | NA |
| Mol.F. | C10H11N3O6 |
| Mol.Wt. | 269.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014847 |
| CAS No | NA |
| Mol.F. | C10H13N3O4 |
| Mol.Wt. | 239.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014848 |
| CAS No | NA |
| Mol.F. | C7H13N3O : C2HF3O2 |
| Mol.Wt. | 155.2 : 114.0 |
| INV STATUS | In Stock |
| CAT No | SRC-N014849 |
| CAS No | NA |
| Mol.F. | C7H13N3O : C2HF3O2 |
| Mol.Wt. | 155.2 : 114.0 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014850 |
| CAS No | NA |
| Mol.F. | C14H15N3O3 |
| Mol.Wt. | 273.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014851 |
| CAS No | NA |
| Mol.F. | C14H19N3O |
| Mol.Wt. | 245.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014852 |
| CAS No | NA |
| Mol.F. | C16H15F3N2O5 |
| Mol.Wt. | 372.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014853 |
| CAS No | NA |
| Mol.F. | C22H25FN4O5 |
| Mol.Wt. | 444.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014854 |
| CAS No | NA |
| Mol.F. | C21H23FN4O5 |
| Mol.Wt. | 430.4 |
| INV STATUS | CUSTOM SYNTHESIS |